I. García

Biodistribution and internal dosimetry of the 188Re-labelled humanized monoclonal antibody anti-epidemal growth factor receptor, nimotuzumab, in the locoregional treatment of malignant gliomas

A. Casacó, R. Leyva, M. Coca, 2008, Nuclear medicine communications.

Loco-regional radioimmunotherapy of high grade malignant gliomas using the humanized monoclonal antibody, h-R3, labeled with 188-Re.

A. Casacó, R. Leyva, L. Díaz, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I single-dose study of intracavitary-administered Nimotuzumab labeled with 188-Re in adult recurrent high-grade glioma

A. Casacó, R. Leyva, M. Coca, 2008, Cancer biology & therapy.

Optimizing CIGB-300 intralesional delivery in locally advanced cervical cancer

D. Alonso, A. Perera, P. López-Saura, 2015, British Journal of Cancer.